
Weekly DigestOCT 181 min read
AM Weekly · Week 42: Medyssey, Myrava and Providence received FDA 510(k) clearances for AM medical devices
Capital intensity is the applicable pattern: 6K Additive’s up to $27.4 million EXIM financing, Vilory’s RMB 100 million Series C+, Amaero’s approximately $20 million.










